Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 02, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Merck Millipore Introduces Parteck® SLC
Wednesday, October 23, 2013
Delivers dramatically increased solubility and bioavailability.

New Innovative Touch Screen Peristaltic Pump
Friday, October 18, 2013
New Allegro™ Peristaltic Pump System is available in three models.

Ultra-Flat Glass Bottom Plates Optimize Imaging of Growing Cells
Thursday, October 10, 2013
New generation Krystal™ glass bottom plates from Porvair.

Waters Introduces the ACQUITY QDa Detector
Monday, October 07, 2013
The Waters® ACQUITY QDa™ Detector is the first mass detector to bring high-quality, mass spectral data to chromatographic separations.

Mettler Toledo Launches New Analytical Balance Line
Thursday, October 03, 2013
Intelligent features ensure compliance and process security.

Nylon Membrane Filter Produces Highly Effective Reduction of Endotoxins
Thursday, October 03, 2013
Hydrofil HTZ from Porvair Filtration Group.

Product Launches at Lab Innovations 2013
Tuesday, October 01, 2013
Over 40% of exhibitors at Lab Innovations 2013 are using the show to launch new technologies and services into the UK.

A New Generation Screening Collection (AXXDIV2.0) is Now Available for Drug Discovery Programs
Thursday, September 26, 2013
Axxam S.p.A. announced that an entirely new generation screening collection is now available for drug discovery programs: AXXDIV2.0 made up with 240,000 carefully selected small molecules.

Fast & Precise Biomass Analysis Tool
Friday, September 13, 2013
The Model 440 Elemental Analyzer analyze a sample in 6 minutes.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 1259
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv